Titan Pharmaceuticals, Inc. - Common Stock (NQ:TTNP)

4.610 UNCHANGED

Last Price Updated: 3:19 PM EDT, Oct 1, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	4.610
Bid (Size)	5.910 (5)
Ask (Size)	5.980 (2)
Prev. Close	4.610
Today's Range	4.610 - 4.610
52wk Range	4.610 - 4.610
Shares Outstanding	1,330,234
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

October 03, 2025

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

Black Titan Corporation (BTTC) Plummets 58.30% Amidst Post-Merger Volatility

October 03, 2025

New York, NY – October 3, 2025 – Black Titan Corporation (NYSE: BTTC) witnessed a dramatic 58.30% decline in its stock price today, a sharp reversal after an astonishing nearly 300% surge just...

Via MarketMinute

Performance

More News

Thursday's after hours session: top gainers and losers ↗

October 02, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 27, 2025

Via Benzinga

Titan Pharmaceuticals Stock Surges 23% After Hours on Stockholder Approval of Three-Way Merger ↗

August 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 26, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 13, 2025

Via Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders

August 06, 2025

From Halper Sadeh LLC

Via GlobeNewswire

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

August 05, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025

July 31, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders

July 26, 2025

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 22, 2025

Via Benzinga

US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted' ↗

April 14, 2025

Via Benzinga

Goldman Sachs, M&T Bank And 3 Stocks To Watch Heading Into Monday ↗

April 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 11, 2025

Via Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders

September 10, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iteris, Inc. (Nasdaq - ITI), Forza X1, Inc. (Nasdaq - FRZA), Titan Pharmaceuticals, Inc. (Nasdaq - TTNP), Gatos Silver, Inc. (NYSE - GATO)

September 09, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders

September 05, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders

August 24, 2024

From Halper Sadeh LLC

Via GlobeNewswire

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

August 22, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Frequently Asked Questions

Is Titan Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Titan Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Titan Pharmaceuticals, Inc. - Common Stock trade on?

Titan Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Titan Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Titan Pharmaceuticals, Inc. - Common Stock is TTNP on the Nasdaq Stock Market

What is the current price of Titan Pharmaceuticals, Inc. - Common Stock?

The current price of Titan Pharmaceuticals, Inc. - Common Stock is 4.610

When was Titan Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Titan Pharmaceuticals, Inc. - Common Stock was at 10/01/25 03:19 PM ET

What is the market capitalization of Titan Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Titan Pharmaceuticals, Inc. - Common Stock is 6.13M

How many shares of Titan Pharmaceuticals, Inc. - Common Stock are outstanding?

Titan Pharmaceuticals, Inc. - Common Stock has 6M shares outstanding.